Globus Medical (GMED) Cash & Current Investments (2011 - 2026)

Globus Medical (GMED) has 16 years of Cash & Current Investments data on file, last reported at $629.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 36.55% year-over-year to $629.9 million; the trailing twelve-month figure through Mar 2026 stood at $629.9 million (up 36.55% YoY), and the FY2025 full-year result was $557.2 million, down 37.39% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $629.9 million, up from $557.2 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $890.1 million in Q4 2024 and bottomed at $229.4 million in Q2 2025.
• The 5-year median for Cash & Current Investments is $473.3 million (2022), against an average of $506.9 million.
• The widest annual swing landed in 2024, when Cash & Current Investments jumped 71.9%; it then slumped 53.45% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $446.1 million in 2022, then gained by 16.08% to $517.8 million in 2023, then surged by 71.9% to $890.1 million in 2024, then sank by 37.39% to $557.2 million in 2025, then advanced by 13.03% to $629.9 million in 2026.
• The last three Cash & Current Investments figures came in at $629.9 million (Q1 2026), $557.2 million (Q4 2025), and $390.5 million (Q3 2025), per Business Quant data.

Peer Comparison